Amoxicillin-Clavulanate (Amoxiclav) Dosing
For adults with respiratory tract infections or moderate-to-severe bacterial infections, prescribe amoxicillin-clavulanate 875 mg/125 mg twice daily as the standard dose, or escalate to 2000 mg/125 mg twice daily when antibiotic resistance is likely or infection severity warrants higher dosing. 1, 2, 3
Standard Adult Dosing
- 875 mg/125 mg twice daily is the recommended dose for acute bacterial rhinosinusitis, community-acquired pneumonia, acute exacerbations of chronic bronchitis, and skin/soft tissue infections 2, 3
- For mild-to-moderate infections, 500 mg/125 mg three times daily provides adequate coverage 2
- Animal or human bite infections require 875 mg/125 mg twice daily for 5-7 days 4
- The medication may be taken without regard to meals, though absorption of clavulanate is enhanced when taken at the start of a meal, which also minimizes gastrointestinal intolerance 3
High-Dose Adult Formulations
Use 2000 mg/125 mg twice daily when any of the following risk factors are present 1, 2:
- Recent antibiotic use (within the past 30 days)
- Geographic regions with >10% prevalence of penicillin-nonsusceptible Streptococcus pneumoniae
- Severe infection (frontal or sphenoidal sinusitis, moderate-to-severe pneumonia)
- Age >65 years
- Recent hospitalization or close contact with healthcare environments
- Immunocompromised status or significant comorbidities (diabetes, chronic heart/lung/liver/kidney disease)
- Smoking or household exposure to smoke
- Close contact with daycare facilities
- History of recurrent infections or prior antibiotic therapy failure
This high-dose formulation achieves adequate serum concentrations to eradicate S. pneumoniae with amoxicillin MICs up to 4-8 mg/L 1, 5
Pediatric Dosing
Standard dose: 45 mg/kg/day of amoxicillin component divided twice daily (or 40 mg/kg/day divided three times daily for less severe infections) 1, 2
High-dose: 90 mg/kg/day of amoxicillin with 6.4 mg/kg/day of clavulanate in two divided doses for 6, 1, 2:
- Acute bacterial rhinosinusitis
- Acute otitis media in children who received amoxicillin in the previous 30 days or with otitis-conjunctivitis
- Suspected resistant infections
For children <12 weeks, use 25 mg/kg/day every 12 hours or 20 mg/kg/day every 8 hours 1
Duration of Therapy
- Respiratory tract infections: 7-10 days 1
- Acute bacterial rhinosinusitis (adults): 5-7 days 1
- Acute bacterial rhinosinusitis (children): 10-14 days 2
- Skin and soft tissue infections: 5-7 days after clinical improvement 4
- Uncomplicated urinary tract infections: 3-7 days 1
- Community-acquired pneumonia: 7-10 days, may extend to 14 days based on clinical response 1
Intravenous Dosing
- Moderate-to-severe community-acquired pneumonia: 1.2 g IV every 8 hours 4
- Intra-abdominal infections (non-critically ill, adequate source control): 2 g/0.2 g IV every 8 hours 1, 4
- Pediatric IV dosing: 30 mg/kg three times daily, increase to four times daily in severe infections for patients >3 months 1
Renal Dosing Adjustments
- Patients with glomerular filtration rate <30 mL/min should not receive the 875 mg dose 3
- Dose reduction is generally not required unless renal impairment is severe 3
Critical Dosing Pitfalls to Avoid
- Do not underdose in high-resistance areas—always use high-dose formulations (2000 mg/125 mg twice daily for adults or 90 mg/kg/day for children) when penicillin-resistant S. pneumoniae prevalence exceeds 10% 1
- Avoid macrolides and trimethoprim-sulfamethoxazole as first-line therapy due to high resistance rates 2
- Do not use fluoroquinolones as first-line in non-penicillin-allergic patients despite comparable efficacy, due to higher adverse event rates and need for antimicrobial stewardship 2
- Evaluate clinical response within 48-72 hours of initiating therapy to determine need for alternative management 1
- Complete the full treatment course to prevent treatment failure and resistance development 2
Penicillin-Allergic Patients
For patients with penicillin allergy, use doxycycline 100 mg twice daily or respiratory fluoroquinolones (levofloxacin 750 mg daily or moxifloxacin 400 mg daily) instead 2